Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations (Q44854376)

6 December 2017

Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations (English)

1 reference

6 December 2017

0 references

1 reference

10

1 reference

6 December 2017

13

1 reference

6 December 2017

17

1 reference

6 December 2017

Jean-Claude Chèvre

2

0 references

Kirsten Ward

object named as

Kirsten J Ward

3

0 references

Oluf Borbye Pedersen

object named as

Oluf Pedersen

15

0 references

David Meyre

16

object named as

David Meyre

1 reference

6 December 2017

Michael Benzinou

1

1 reference

6 December 2017

Cécile Lecoeur

4

1 reference

6 December 2017

Christian Dina

5

1 reference

6 December 2017

Stephane Lobbens

6

1 reference

6 December 2017

Emmanuelle Durand

7

1 reference

6 December 2017

Jérome Delplanque

8

1 reference

6 December 2017

Fritz F Horber

9

1 reference

6 December 2017

Beverley Balkau

11

1 reference

6 December 2017

Knut Borch-Johnsen

12

1 reference

6 December 2017

Torben Hansen

14

1 reference

6 December 2017

28 March 2008

1 reference

6 December 2017

Human Molecular Genetics

1 reference

6 December 2017

17

1 reference

6 December 2017

13

1 reference

6 December 2017

1916-1921

1 reference

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol

6 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Lack of CB1 cannabinoid receptor impairs cocaine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

The endocannabinoid system and the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

The unfolding cannabinoid story on energy homeostasis: central or peripheral site of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

On estimating the relation between blood group and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Exact inference for categorical data: recent advances and continuing controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Binge eating as a major phenotype of melanocortin 4 receptor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Pedigree disequilibrium tests for multilocus haplotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Genetic Variations at the Endocannabinoid Type 1 Receptor Gene (CNR1) Are Associated with Obesity Phenotypes in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN089

21 January 2018

Identifiers

DOI

10.1093/HMG/DDN089

1 reference

6 December 2017

1 reference